CMS Hasche Sigle advises Bruker on sale of division to Analytik Jena

Frankfurt/Main - US technology company Bruker Corporation is selling its Inductively Coupled Plasma Mass Spectrometry (ICP-MS) business to Analytik Jena AG. The acquisition is expected to close in September. The purchase price was not disclosed. As part of the asset deal, Analytik Jena will acquire patents, licensing rights, global research, development and production capacity as well as most of the employees in the ICP-MS division.

A team from CMS Hasche Sigle headed by lead partner Dr Hendrik Hirsch advised the vendor, Bruker Daltonics Inc., a subsidiary of Bruker Corporation, on all legal aspects of the sale.

ICP-MS technology is a special form of analysis used to detect a wide range of elements. The method is in very high demand throughout the world due to its sensitivity. Applications include geochemistry, materials science, semiconductor analysis, food testing, pharmaceutical clinical analysis, forensics and environmental studies. NASDAQ-listed Bruker Corporation of Billerica, Massachusetts, employs more than 6,000 people worldwide. It has annual sales of around USD 2 billion in instrumental analytics technology. Analytik Jena is a listed international provider of instruments and products for analytical measuring technology, life science and optoelectronics. The company’s portfolio includes analytical technology, complete systems for bioanalytical applications in the life science area and high-end optical consumer products.

CMS Hasche Sigle

Dr Hendrik Hirsch, Corporate/M&A, Lead Partner 
Dr Rainer Freudenberg, Corporate/M&A 
Dr Björn Otto 
Andreas Hofelich, both Employment 
Gerd Schönen, Intellectual Property 
Marcus Fischer, Tax

Press Contact
presse@cms-hs.com